• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Hillrom

Baxter’s Volara lung therapy system recall is Class I

June 23, 2022 By Sean Whooley

The FDA issued a notice today labeling the recall of the Baxter (NYSE:BAX) Volara lung therapy system as Class I, the most serious kind. Earlier this month, Baxter announced that it issued an urgent medical device correction for its Volara system for oscillation and lung expansion (OLE) therapy. To date, there has been one complaint […]

Filed Under: Featured, Food & Drug Administration (FDA), News Well, Recalls, Regulatory/Compliance, Respiratory Tagged With: Baxter, FDA, Hillrom

Baxter completes $12.5B acquisition of Hillrom

December 13, 2021 By Sean Whooley

Baxter (NYSE:BAX) announced today that it completed its previously announced $12.5 billion acquisition of Hillrom (NYSE:HRC). Deerfield, Illinois–based Baxter paid $156 in cash for each outstanding share of Hillrom common stock, totaling a purchase price of $10.5 billion. Adding in the assumption of Hillrom’s outstanding debt obligations, the transaction’s enterprise value comes to approximately $12.5 […]

Filed Under: Business/Financial News, Digital Health, Featured, Health Technology, MassDevice Earnings Roundup, Mergers & Acquisitions, Patient Monitoring, Wall Street Beat Tagged With: Baxter, Hillrom

Baxter, 3M, Abbott near the top of Newsweek’s most responsible companies list

December 3, 2021 By Sean Whooley

Several medtech, healthcare and life sciences companies, including big names like Abbott (NYSE:ABT), 3M (NYSE:MMM) and Baxter (NYSE:BAX), are among the 500 “most responsible,” according to Newsweek. The outlet published its “America’s Most Responsible Companies 2022” list, marking the third installment of the compilation (in partnership with Statista), this time expanded to include 500 of […]

Filed Under: Business/Financial News, Featured, News Well Tagged With: 3m, Abbott, Amerisource Bergen, Avanos Medical (formerly Halyard Health), Baxter, BD, Biogen, Boston Scientific, Cantel Medical Corp., Cardinal Health, Edwards Lifesciences, Gilead Sciences, Henry Schein, Hillrom, Hologic, Illumina Inc., Insulet, LabCorp, Merck, Pfizer, Quest Diagnostics Inc., ResMed, Thermo Fisher Scientific, Varex Imaging, Varian Medical Systems

Medtech M&A: The industry’s biggest mergers and acquisitions of 2021

November 5, 2021 By Sean Whooley

Across 2021, medtech has seen a wide range of mergers and acquisitions covering several areas of devices, pharmaceuticals and more. Some have gone off without a hitch, while others fell into serious scrutiny as mouthwatering financial figures were revealed and major technologies were acquired. Here are the 10 biggest mergers and acquisitions in medtech in […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Baxter, Boston Scientific, GE Healthcare, Grail, Hillrom, Illumina Inc., Medtronic, PerkinElmer Inc., Philips, Roche, Sanofi, Siemens Healthineers, Thermo Fisher Scientific, Varian Medical Systems, Vectura

Hillrom posts Street-beating Q4 as Baxter merger remains on track

November 5, 2021 By Sean Whooley

Hillrom (NYSE:HRC) shares were relatively unmoved on fourth-quarter results that finished well ahead of the consensus forecast. The Chicago-based connected care technology developer posted profits of $53.4 million, or 80¢ per share, on sales of $797.9 million for the three months ended Sept. 30, 2021, for a 25.9% bottom-line gain on sales growth of 13.1%. […]

Filed Under: Big Data, Business/Financial News, Digital Health, Electronic Medical Records (EMR), Featured, Health Technology, MassDevice Earnings Roundup, Mergers & Acquisitions, Software / IT, Wall Street Beat Tagged With: Baxter, Hillrom

Hillrom’s business outlook is better-than-expected as Baxter prepares to acquire

October 4, 2021 By Sean Whooley

Analysts are pleased with Hillrom’s (NYSE:HRC) position following a proxy statement last week as it nears its merger with Baxter (NYSE:BAX). Baxter announced last month that it agreed to buy Hillrom for approximately $12.4 billion, with Hillrom shareholders set to receive $156 per common stock share as the company will survive the merger as a […]

Filed Under: Business/Financial News, Digital Health, Featured, Health Technology, Mergers & Acquisitions, Patient Monitoring, Wall Street Beat Tagged With: Baxter, Hillrom

Baxter to acquire Hillrom for $12.4B

September 2, 2021 By Sean Whooley

Baxter (NYSE:BAX) announced today that it entered into a definitive agreement to acquire Hillrom (NYSE:HRC) for approximately $12.4 billion. Rumblings of a potential deal surfaced earlier this week, leading to a massive rise for Hillrom’s stock. The expectation was that the companies would reach a deal by midweek so long as talks didn’t fall apart. Those […]

Filed Under: Business/Financial News, Digital Health, Featured, Health Technology, Mergers & Acquisitions, Patient Monitoring, Wall Street Beat Tagged With: Baxter, Hillrom

Hillrom stock skyrockets amid reports that Baxter is close to acquisition

August 30, 2021 By Sean Whooley

Baxter (NYSE:BAX) is reportedly in advanced talks to acquire Hillrom (NYSE:HRC) for approximately $10 billion. The Wall Street Journal reported yesterday that the talks were ongoing at an advanced stage. WSH previously reported on rumblings of a potential deal last month. Hillrom’s stock shot up when that report came out, and it’s rising again today, […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Patient Monitoring, Wall Street Beat Tagged With: Baxter, Hillrom

MedTech 100 roundup: Industry climbs with earnings season in full swing

August 2, 2021 By Sean Whooley

Better-than-expected quarterly earnings are providing a further boost to medtech industry stocks. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (July 30) at 118.86 points. Two weeks ago aside — when the index shot up to 145.88 points and quickly tumbled down — this mark […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: 3m, Baxter, BD, Boston Scientific, coronavirus, COVID-19, Dexcom, Edwards Lifesciences, GE Healthcare, Hillrom, Hologic, MedTech 100 Index, Pfizer, Philips, Smith+Nephew, Stryker, Tenaya Therapeutics

Hillrom beats The Street in Q3, raises guidance

July 30, 2021 By Sean Whooley

Hillrom (NYSE: HRC) shares slightly dipped today on third-quarter results that beat the consensus forecast. The Chicago-based company posted profits of $49.2 million, or 74¢ per share, on sales of $717.7 million for the three months ended June 30, 2021, for a -47.6% bottom-line slide on a sales decline of -6.5%. Adjusted to exclude one-time […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Bardy Diagnostics, Baxter, Hillrom

Hillrom stock shoots up on news of potential acquisition by Baxter

July 28, 2021 By Chris Newmarker

Hillrom (NYSE: HRC) stock rocketed today after a Wall Street Journal report that Baxter (NYSE: BAX)  is in the early stages of talks to acquire the company. WSJ cited people familiar with the matter, who added that there was no guarantee the two companies will reach an agreement. HRC shares are up 8.7% to $134.49 […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Patient Monitoring, Wall Street Beat Tagged With: Baxter, Hillrom

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 13
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS